Literature DB >> 31189987

Gene therapy to inhibit CaMKII in CPVT.

Gregory B Lim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31189987     DOI： 10.1038/s41569-019-0226-x

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II.

Authors:  Vassilios J Bezzerides; Ana Caballero; Suya Wang; Yulan Ai; Robyn J Hylind; Fujian Lu; Danielle A Heims-Waldron; Kristina D Chambers; Donghui Zhang; Dominic J Abrams; William T Pu
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690
  1 in total
  1 in total

1.  Involvement of CaMKII in regulating the release of diplotene-arrested mouse oocytes by pAkt1 (Ser473).

Authors:  Lingling Liu; Hanwen Li; Ben Labbe; Yang Wang; Shitao Mao; Yu Cao; Mingjing Zhao; Shuo Liu; Hang Yu; Xin Deng
Journal:  Cell Cycle       Date:  2019-09-18       Impact factor: 4.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.